Press Releases

EIN Presswire

Swiss hyper-local Agentic AI platform, schaffhausen.live by Berg Digital, has won Silver at the Best of Swiss Web 2026 SCHAFFHAUSEN, SWITZERLAND, May 20, 2026 /⁨EINPresswire.com⁩/ -- In a historic first for the region, Berg Digital is proud to...

EIN Presswire

GENEVA, SWITZERLAND, May 20, 2026 /⁨EINPresswire.com⁩/ -- King Faisal Specialist Hospital & Research Centre (KFSH) is highlighting the growing role of emerging healthcare systems in shaping the next phase of artificial intelligence in health,...

EIN Presswire

Dentavit pioneers biological dentistry and holistic orthodontics in Switzerland, bridging the gap between oral health and total body wellness.

GlobeNewswire, Inc.

Initiated a rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tinlarebant for the treatment of Stargardt disease type 1 (STGD1); submission expected to be completed in the second quarter of 2026...

EIN Presswire

GUANGZHOU, CHINA, May 19, 2026 /⁨EINPresswire.com⁩/ -- In April 2026, Diode Machining, a premier provider of precision components, announces the strategic expansion of its High-Precision Swiss Machining Services for Metal Shafts, setting a new...

GlobeNewswire, Inc.

BEDFORD, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient...

GlobeNewswire, Inc.

BASEL, Switzerland, May 19, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage biotechnology company pioneering precision biologics to reprogram the immune system for the treatment of autoimmune and inflammatory diseases, today announced the...

GlobeNewswire, Inc.

EINDHOVEN, The Netherlands, May 19, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord...

EIN Presswire

Driving Industrial Automation with Safety, Reliability, and Precision CALIFORNIA, CA, UNITED STATES, May 19, 2026 /⁨EINPresswire.com⁩/ -- Wenzhou, Zhejiang，May 19, 2026——The industrial control pendant—often referred to as a pendant control...

GlobeNewswire, Inc.

Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in Stargardt disease, having met the primary endpoint, reductions in lesion growth rate, in the pivotal, global Phase 3 DRAGON trial Company recently initiated a...

GlobeNewswire, Inc.

IPAX-2 study of TLX101-Tx (¹³¹I-iodofalan) has completed patient enrolment.

EIN Presswire

NEW YORK, NY, UNITED STATES, May 18, 2026 /⁨EINPresswire.com⁩/ -- The American Swiss Foundation (ASF) hosted its 81st Annual Gala on Tuesday, May 12th, at the Harvard Club in New York City, honoring Andreas Berger, Group Chief Executive Officer of...

GlobeNewswire, Inc.

Key highlights from the first quarter of operations under the expanded management team include the following: Anticipated FDA decision on the Company's ANDA for Preservative-Free Ketamine in Q3 2026, with favorable preliminary determinations...

EIN Presswire

Teen readers worldwide can now explore mysteries, culture, inspiration, and creative adventures in one immersive platform.

EIN Presswire

Global Health Leaders Call for Suicide Prevention to be Embedded in AI Chatbots and Online Safety Policy GENEVA, DC, UNITED STATES, May 17, 2026 /⁨EINPresswire.com⁩/ -- Health leaders are calling for suicide prevention to be embedded in artificial...

EIN Presswire

New AI Resume Analyzer, Feedback-First Interface and Real-Time Salary Benchmarking Tool Set a New Global Standard for Fintech Recruitment in the US and the UK. NEW YORK, NY, UNITED STATES, May 20, 2026 /⁨EINPresswire.com⁩/ -- Finjobsly the...

GlobeNewswire, Inc.

SUMMARY: Preferred Hotels & Resorts has launched Preferred Wellbeing, a new global designation spotlighting more than 50 hotels delivering immersive, holistic wellness experiences.

GlobeNewswire, Inc.

WILMETTE, Ill., May 14, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today...

GlobeNewswire, Inc.

Reports first quarter 2026 total revenue of $8.0 million, representing 11% growth compared to the first quarter of 2025 Placed 6 Growth Direct systems in the first quarter 2026 compared to 3 systems in the first quarter of 2025 First quarter 2026...

GlobeNewswire, Inc.

Initiation of SLIM-1™ clinical trial, a Phase 1 study of NPM-139, a semaglutide implant under development for chronic weight management, on track for mid-year 2026 $28 million in cash, cash equivalents, restricted cash and capital commitments...